Nintedanib en esclerosis sistémica pos hoc
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
(Club de Revista 043) En el club de revista revisamos el reporte pos hoc del estudio fase III de Nintedanib para enfermedad pulmonar intersticial asociada a esclerosis sistémica. ENLACE: https://bit.ly/3bnOMRn
show moreENLACE: https://bit.ly/3bnOMRn
Information
Author | MedicCreative |
Organization | Reumatología ONLINE |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company